Open menu
Nanowerk

Nanotechnology General News

The latest news from academia, regulators
research labs and other things of interest

Gold nanoparticles could be the key to developing a treatment for pancreatic cancer

(Nanowerk News) A diagnosis of pancreatic cancer is often a death sentence because chemotherapy and radiation have little impact on the disease. In the U.S. this year, some 53,000 new cases will be diagnosed, and 42,000 patients will die of the disease, according to the National Institutes of Health. But research now being reported in ACS Nano ("Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth") could eventually lead to a new type of treatment based on gold nanoparticles.
gold nanoparticles inhibit proliferation and migration of both PCCs and PSCs
Gold nanoparticles (AuNPs) inhibit proliferation and migration of both PCCs and PSCs by disrupting the bidirectional communication via alteration of the cell secretome. (© ACS)
Scientists have previously studied these tiny gold particles as a vehicle to carry chemotherapy drug molecules into tumors or as a target to enhance the impact of radiation on tumors. In addition, Priyabrata Mukherjee and colleagues previously found that gold nanoparticles themselves could limit tumor growth and metastasis in a model of ovarian cancer in mice.
Now, the team has determined that the same holds true for mouse models of pancreatic cancer. But interestingly, the new work revealed details about cellular communication in the area surrounding pancreatic tumors. By interrupting this communication -- which is partly responsible for this cancer's lethal nature -- the particles reduced the cell proliferation and migration that ordinarily occurs near these tumors. Gold nanoparticles of the size used in the new study are not toxic to normal cells, the researchers note.
Source: American Chemical Society
Subscribe to a free copy of one of our daily
Nanowerk Newsletter Email Digests
with a compilation of all of the day's news.
 
These articles might interest you as well: